CCIS
Contact & Feedback CRA

Post-Market Clinical Follow-Up Study of the VascuPath 3F Interventional Catheter

PMCF-2024-CAT-001 · VascuPath 3F Interventional Catheter · PMCF


Priority Queue — Action Required

SAE — SAE-001

Site 04 — Hamburg

Safety / Vigilance

Day 254 of 15

Severity: serious | Status: open | OVERDUE — immediate action required

COMPLAINT — SAE-002

Site 07 — Lyon

Complaint

Day 243 of 15

Severity: complaint | Status: open | OVERDUE — immediate action required

Silent Site — 262 days no contact

Site 02 — Amsterdam

Silence Flag

262 days silent

No communication for 262 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 253 days no contact

Site 04 — Hamburg

Silence Flag

253 days silent

No communication for 253 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 247 days no contact

Site 05 — Vienna

Silence Flag

247 days silent

No communication for 247 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 245 days no contact

Site 08 — Warsaw

Silence Flag

245 days silent

No communication for 245 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 244 days no contact

Site 03 — Barcelona

Silence Flag

244 days silent

No communication for 244 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 242 days no contact

Site 01 — Brussels

Silence Flag

242 days silent

No communication for 242 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 241 days no contact

Site 07 — Lyon

Silence Flag

241 days silent

No communication for 241 days (threshold: 14 days). Re-engagement recommended.

Silent Site — 240 days no contact

Site 06 — Milan

Silence Flag

240 days silent

No communication for 240 days (threshold: 14 days). Re-engagement recommended.

Protocol Deviation Notification — Visit Window Exceeded — Subject 06-0

Site 06 — Milan

Protocol Deviation

Received: 14 Mar 2026 08:30

Category: Protocol Deviation | Classification: classified | Confidence: 90%



Enrollment Progress

Monitor Your Team as a Manager

Step 7 of 7

Done! The Manager view gives directors full visibility into CRA workload and site health — with zero disruption to daily CRA work.

New Message
To:
CC: —
Subject:
DEMO SIMULATION

Electronic Signature

21 CFR Part 11 · EU Annex 11

By signing, you confirm the accuracy and completeness of this record. Your identity and the meaning of this signature will be recorded in the audit trail.

Demo: any password accepted

Signature Applied

Signed by:
Date/Time:
Meaning: